Immunoassays

COVELISA®COVID-19 IgM ELISA is an in-vitro semi-quantitative detection test of human antibodies of the immunoglobulin class IgM directed against SARS-CoV-2.

The Respiratory Syncytial Virus IgA ELISA is intended for the qualitative determination of IgA class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin).

The Respiratory Syncytial Virus IgG ELISA is intended for the qualitative determination of IgG class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin).

The Respiratory Syncytial Virus IgM ELISA is intended for the qualitative determination of IgM class antibodies against respiratory syncytial virus in human serum or plasma (citrate, heparin).

The Rubella Virus IgG ELISA is intended for the quantitative determination of IgG class antibodies against Rubella Virus in human serum or plasma (citrate, heparin).

The Rubella Virus IgM μ-capture ELISA is intended for the qualitative determination of IgM-class antibodies against Rubella Virus in human serum or plasma (citrate, heparin).

The NovaTec TBE/FSME IgG ELISA is intended for the quantitative determination of IgG class antibodies against TBE virus in human serum or plasma (citrate, heparin).

The TBE/FSME Virus IgM ELISA is intended for the qualitative determination of IgM class antibodies against TBE/FSME Virus in human serum or plasma (citrate, heparin).

Der Varicella-Zoster Virus (VZV) IgA ELISA ist für den qualitativen Nachweis spezifischer IgA-Antikörper gegen Varicella-Zoster Virus (VZV) in humanem Serum oder Plasma (Citrat, Heparin) bestimmt.

The Varicella-Zoster Virus (VZV) IgG ELISA is intended for the qualitative determination of IgG class antibodies against Varicella-Zoster Virus (VZV) in human serum or plasma (citrate, heparin).